SAN MATEO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at two upcoming conferences in New York City: the Oppenheimer & Co. 20th Annual Healthcare Conference, to be held November 3-4, 2009 and the Lazard Capital Markets 6th Annual Healthcare Conference, taking place November 17-18, 2009.
Mr. DiTonno and Stephen Ghiglieri, Chief Financial Officer, will also be available to respond to questions following the presentations and to participate in one-on-one meetings with investors attending the conferences.
Event: Oppenheimer & Co. Healthcare Conference Date: Tuesday, November 3, 2009 Time: 3:55 p.m. ET Place: The Waldorf Astoria Hotel, NYC (East Foyer - Third Floor) Event: Lazard Capital Markets Healthcare Conference Date: Tuesday, November 17, 2009 Time: 11:25 p.m. ET Place: The St. Regis Hotel, NYC (Louis XVI A, Second Floor)
Both presentations will be webcast live and can be accessed by visiting the investor relations section of NeurogesX' website at www.neurogesx.com. The webcasts will be archived for 90 days.
About NeurogesX, Inc.
NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (
|SOURCE NeurogesX, Inc.|
Copyright©2009 PR Newswire.
All rights reserved